Chunlei Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Chunlei Zhu has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
Minghui Xiao
Key Laboratory of Functional Polymer Materials of Ministry of Education State Key Laboratory of Medicinal Chemical Biology Frontiers Science Center for New Organic Matter College of Chemistry Nankai University Tianjin China
21 shared publicationsKe Xue
Key Laboratory of Functional Polymer Materials of Ministry of Education, State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Functional Polymer Materials, Frontiers Science Center for New Organic Matter, College of Chemistry, Nankai University, Tianjin 300071, China
17 shared publicationsShuyi Lv
Key Laboratory of Functional Polymer Materials of Ministry of Education State Key Laboratory of Medicinal Chemical Biology Frontiers Science Center for New Organic Matter College of Chemistry Nankai University Tianjin China
17 shared publicationsZhencheng Sun
Key Laboratory of Functional Polymer Materials of Ministry of Education State Key Laboratory of Medicinal Chemical Biology Frontiers Science Center for New Organic Matter College of Chemistry Nankai University Tianjin China
13 shared publicationsCheng Wang
Key Laboratory of Functional Polymer Materials of Ministry of Education State Key Laboratory of Medicinal Chemical Biology Frontiers Science Center For New Organic Matter, College of Chemistry Nankai University Tianjin China
10 shared publicationsLinqi Shi
Key Laboratory of Functional Polymer Materials of Ministry of Education State Key Laboratory of Medicinal Chemical Biology Frontiers Science Center For New Organic Matter, College of Chemistry Nankai University Tianjin China
10 shared publications
Latest Publications
- Open Access
- 13 September 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (38) , e71709
Phase‐Transition‐Induced Deformable OMV‐Camouflaged Nanoparticles Enabling Deep Biofilm Penetration for Photothermal–Photodynamic Eradication of Bacterial Pneumonia
Bacterial pneumonia remains refractory to conventional therapies due to the dense extracellular polymeric substance matrix of biofilms that severely restricts drug penetration. Here, we report a biomimetic, thermo‐responsive nanoplatform (AIE/PCM@OMV) featuring phase‐transition‐induced deformability to overcome biofilm barriers and treat bacterial pneumonia. The nanoparticles comprise a phase‐change material (PCM) core encapsulating an aggregation‐induced emission (AIE) phototherapeutic agent and are camouflaged with bacterial outer membrane vesicles (OMVs). The OMV coating enables homologous targeting and preferential accumulation within biofilms derived from the parental strain. Upon 660 nm laser irradiation, the AIE agent simultaneously generates localized heat and reactive oxygen species, inducing synergistic photothermal–photodynamic bacterial ablation while triggering a solid‐to‐liquid transition of the PCM core. This phase transition confers dynamic deformability, allowing adaptive structural transformation and deep penetration into biofilms. AIE/PCM@OMV achieves 99.9% eradication of wild‐type Escherichia coli biofilms in vitro and reduces pulmonary bacterial burden by 99% in a murine pneumonia model, alleviating lung edema and restoring alveolar architecture. Mechanistically, the therapy reprograms the immune microenvironment by suppressing excessive inflammatory signaling and promoting M2 macrophage polarization. This work establishes a phase‐transition‐driven deformable biomimetic nanostrategy that integrates homologous targeting, adaptive penetration, and synergistic photothermal–photodynamic therapy for effective treatment of biofilm‐associated bacterial pneumonia.
- 13 September 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (38) , e71709
Open AccessPhase‐Transition‐Induced Deformable OMV‐Camouflaged Nanoparticles Enabling Deep Biofilm Penetration for Photothermal–Photodynamic Eradication of Bacterial Pneumonia
Bacterial pneumonia remains refractory to conventional therapies due to the dense extracellular polymeric substance matrix of biofilms that severely restricts drug penetration. Here, we report a biomimetic, thermo‐responsive nanoplatform (AIE/PCM@OMV) featuring phase‐transition‐induced deformability to overcome biofilm barriers and treat bacterial pneumonia. The nanoparticles comprise a phase‐change material (PCM) core encapsulating an aggregation‐induced emission (AIE) phototherapeutic agent and are camouflaged with bacterial outer membrane vesicles (OMVs). The OMV coating enables homologous targeting and preferential accumulation within biofilms derived from the parental strain. Upon 660 nm laser irradiation, the AIE agent simultaneously generates localized heat and reactive oxygen species, inducing synergistic photothermal–photodynamic bacterial ablation while triggering a solid‐to‐liquid transition of the PCM core. This phase transition confers dynamic deformability, allowing adaptive structural transformation and deep penetration into biofilms. AIE/PCM@OMV achieves 99.9% eradication of wild‐type Escherichia coli biofilms in vitro and reduces pulmonary bacterial burden by 99% in a murine pneumonia model, alleviating lung edema and restoring alveolar architecture. Mechanistically, the therapy reprograms the immune microenvironment by suppressing excessive inflammatory signaling and promoting M2 macrophage polarization. This work establishes a phase‐transition‐driven deformable biomimetic nanostrategy that integrates homologous targeting, adaptive penetration, and synergistic photothermal–photodynamic therapy for effective treatment of biofilm‐associated bacterial pneumonia.
- 18 June 2026
- Published by Wiley in Advanced Materials
- Vol. 38 (42) , e73749
Acid‐Triggered, Enzyme‐Enabled EPS‐Degrading Nanoplatform With Enhanced In Situ Retention for Intravenous Biofilm Therapy
Bacterial biofilms present a major challenge to antibacterial therapy due to their dense extracellular polymeric substance (EPS) matrix, which limits nanoparticle penetration and reduces drug efficacy. Here, we report a pH‐responsive, surface charge‐adaptive multifunctional nanosystem (DA‐L@DTTB/Bro) for efficient in vivo treatment of biofilm‐associated infections. The nanosystem integrates pH‐triggered charge adaptation, in situ self‐aggregation, photothermal responsiveness, enzymatic EPS degradation, and NIR‐II imaging. Cationic phospholipid AGPDP, together with cholesterol and thermosensitive DPPC, self‐assembled into liposomes encapsulating bromelain in the hydrophilic core and an NIR‐II‐emissive photothermal agent (DTTB) in the hydrophobic layer. Surface modification with DA‐functionalized chitosan (CS‐DA) generates negatively charged nanoparticles for prolonged circulation. At acidic infection sites, DA hydrolysis restores the cationic surface, enhancing biofilm penetration, while residual CS‐DA induces self‐aggregation to improve retention. NIR irradiation triggers DTTB‐mediated hyperthermia, directly killing bacteria and disassembling liposomes to release bromelain, which degrades EPSs and facilitates biofilm dispersion. The nanosystem eradicates methicillin‐resistant Staphylococcus aureus biofilms in vitro with 99.99% efficiency, enables high‐contrast NIR‐II imaging, persists at abscess sites in vivo, and accelerates wound healing. Furthermore, it demonstrates effective therapeutic activity against biofilm‐associated infections in deep pulmonary tissues. This study presents a versatile intravenous strategy for targeted, synergistic therapy against biofilm‐associated infections in vivo.
- 18 June 2026
- Published by Wiley in Advanced Materials
- Vol. 38 (42) , e73749
Acid‐Triggered, Enzyme‐Enabled EPS‐Degrading Nanoplatform With Enhanced In Situ Retention for Intravenous Biofilm Therapy
Bacterial biofilms present a major challenge to antibacterial therapy due to their dense extracellular polymeric substance (EPS) matrix, which limits nanoparticle penetration and reduces drug efficacy. Here, we report a pH‐responsive, surface charge‐adaptive multifunctional nanosystem (DA‐L@DTTB/Bro) for efficient in vivo treatment of biofilm‐associated infections. The nanosystem integrates pH‐triggered charge adaptation, in situ self‐aggregation, photothermal responsiveness, enzymatic EPS degradation, and NIR‐II imaging. Cationic phospholipid AGPDP, together with cholesterol and thermosensitive DPPC, self‐assembled into liposomes encapsulating bromelain in the hydrophilic core and an NIR‐II‐emissive photothermal agent (DTTB) in the hydrophobic layer. Surface modification with DA‐functionalized chitosan (CS‐DA) generates negatively charged nanoparticles for prolonged circulation. At acidic infection sites, DA hydrolysis restores the cationic surface, enhancing biofilm penetration, while residual CS‐DA induces self‐aggregation to improve retention. NIR irradiation triggers DTTB‐mediated hyperthermia, directly killing bacteria and disassembling liposomes to release bromelain, which degrades EPSs and facilitates biofilm dispersion. The nanosystem eradicates methicillin‐resistant Staphylococcus aureus biofilms in vitro with 99.99% efficiency, enables high‐contrast NIR‐II imaging, persists at abscess sites in vivo, and accelerates wound healing. Furthermore, it demonstrates effective therapeutic activity against biofilm‐associated infections in deep pulmonary tissues. This study presents a versatile intravenous strategy for targeted, synergistic therapy against biofilm‐associated infections in vivo.
- 10 December 2025
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (30)
Biochemically Responsive Bacterial Codes Enabled by Photodynamic AIE Nanoparticles for Advanced Information Encryption
With the escalating risk of information leakage, the development of advanced, high‐security encryption technologies has become increasingly critical. Herein, a novel multilevel information encryption platform is reported based on biochemically responsive bacterial codes, enabled by high‐resolution photodynamic patterning. This system employs positively charged photodynamic nanoparticles, which can form strong electrostatic interactions with negatively charged bacteria; simultaneously, the photosensitizing performance of aggregation‐induced emission photosensitizers is markedly enhanced by restricted intramolecular motions through encapsulation in natural saturated fatty acids. These nanoparticles not only exhibit potent, broad‐spectrum antibacterial activity but also enable precise, high‐contrast bacterial patterning on mixed cellulose membranes. Importantly, the resulting patterns can be reliably transferred across diverse culture media, with exceptional spatial fidelity and functional stability. By harnessing the inherent and unique metabolic characteristics of different bacterial species, a wide spectrum of visible and fluorescent bacterial patterns is generated without the need for genetic modification. This capability allows the construction of biochemically responsive 1D Morse codes, 2D QR codes, and 3‐/4D bacterial codes with reconfigurable and time‐gated features—including “code‐in‐code” architectures that require sequential decoding. By integrating high‐resolution photodynamic control with the biochemical complexity of living systems, this work establishes a versatile platform for secure information storage and anti‐counterfeiting strategies.
- 10 December 2025
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (30)
Biochemically Responsive Bacterial Codes Enabled by Photodynamic AIE Nanoparticles for Advanced Information Encryption
With the escalating risk of information leakage, the development of advanced, high‐security encryption technologies has become increasingly critical. Herein, a novel multilevel information encryption platform is reported based on biochemically responsive bacterial codes, enabled by high‐resolution photodynamic patterning. This system employs positively charged photodynamic nanoparticles, which can form strong electrostatic interactions with negatively charged bacteria; simultaneously, the photosensitizing performance of aggregation‐induced emission photosensitizers is markedly enhanced by restricted intramolecular motions through encapsulation in natural saturated fatty acids. These nanoparticles not only exhibit potent, broad‐spectrum antibacterial activity but also enable precise, high‐contrast bacterial patterning on mixed cellulose membranes. Importantly, the resulting patterns can be reliably transferred across diverse culture media, with exceptional spatial fidelity and functional stability. By harnessing the inherent and unique metabolic characteristics of different bacterial species, a wide spectrum of visible and fluorescent bacterial patterns is generated without the need for genetic modification. This capability allows the construction of biochemically responsive 1D Morse codes, 2D QR codes, and 3‐/4D bacterial codes with reconfigurable and time‐gated features—including “code‐in‐code” architectures that require sequential decoding. By integrating high‐resolution photodynamic control with the biochemical complexity of living systems, this work establishes a versatile platform for secure information storage and anti‐counterfeiting strategies.
- 14 August 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (32) , e02295
Synergistic Eradication of Bacterial Biofilms via Phage‐Driven EPS Disruption and Click‐Activated AIE Photosensitization
Biofilm‐associated infections pose a major clinical challenge due to their robust resistance to conventional antimicrobial treatments, primarily driven by the protective extracellular polymeric substances (EPSs) that shield bacteria. Existing strategies struggle to eliminate mature biofilms effectively. In response, a novel therapeutic approach is developed, which integrates phage T4 with a clickable aggregation‐induced emission photosensitizer, pyone‐TPE‐BT. This approach leverages the unique properties of phage T4, including its polysaccharide depolymerase activity and bacterial infectivity, to degrade EPSs and lyse bacterial cells, thereby dismantling the biofilm structure. The disruption facilitates deeper penetration of pyone‐TPE‐BT, which forms covalent bonds with biofilm components via non‐specific click bioconjugation. This process minimizes the distance between reactive oxygen species and their targets, leading to a significant increase in antibacterial efficacy. The strategy achieves remarkable bacterial eradication against both immature and highly mature biofilms, including host and non‐host bacteria. In vivo studies demonstrate that this combined therapy not only eradicates biofilm infections but also accelerates wound healing by modulating the inflammatory microenvironments. This work establishes a promising platform for treating biofilm‐related infections, holding great potential for overcoming antimicrobial resistance.
- 14 August 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (32) , e02295
Synergistic Eradication of Bacterial Biofilms via Phage‐Driven EPS Disruption and Click‐Activated AIE Photosensitization
Biofilm‐associated infections pose a major clinical challenge due to their robust resistance to conventional antimicrobial treatments, primarily driven by the protective extracellular polymeric substances (EPSs) that shield bacteria. Existing strategies struggle to eliminate mature biofilms effectively. In response, a novel therapeutic approach is developed, which integrates phage T4 with a clickable aggregation‐induced emission photosensitizer, pyone‐TPE‐BT. This approach leverages the unique properties of phage T4, including its polysaccharide depolymerase activity and bacterial infectivity, to degrade EPSs and lyse bacterial cells, thereby dismantling the biofilm structure. The disruption facilitates deeper penetration of pyone‐TPE‐BT, which forms covalent bonds with biofilm components via non‐specific click bioconjugation. This process minimizes the distance between reactive oxygen species and their targets, leading to a significant increase in antibacterial efficacy. The strategy achieves remarkable bacterial eradication against both immature and highly mature biofilms, including host and non‐host bacteria. In vivo studies demonstrate that this combined therapy not only eradicates biofilm infections but also accelerates wound healing by modulating the inflammatory microenvironments. This work establishes a promising platform for treating biofilm‐related infections, holding great potential for overcoming antimicrobial resistance.
- Open Access
A pH‐responsive charge‐reversal liposome with enhanced biofilm penetration for multimodal synergistic therapy of bacterial infections
Biofilm infections pose a significant clinical challenge largely due to the limited penetration of a variety of antibacterial agents, making traditional antibiotic therapies ineffective. In this study, we develop a pH‐responsive, charge‐reversal liposomal system (TPA‐ICN/LVF@Lipo‐PyB) loaded with the phototherapeutic agent TPA‐ICN and the antibiotic levofloxacin (LVF) for multimodal synergistic therapy of methicillin‐resistant Staphylococcus aureus (MRSA) biofilm infections. The surface‐grafted pyridine betaine group enables charge reversal of TPA‐ICN/LVF@Lipo‐PyB through rapid and efficient protonation to enhance its penetration capability in the acidic microenvironment of biofilms. Upon laser irradiation, the liposomal system exhibits both photodynamic and photothermal properties to inactivate bacteria within the biofilm. Simultaneously, the photothermal effect effectively disassembles the liposome due to the presence of thermosensitive phospholipids to trigger LVF release, ensuring the effective eradication of residual bacteria. Remarkably, the multimodal synergistic therapy demonstrates exceptional in vitro bacterial eradication, achieving a 99.99% reduction in MRSA biofilms. Furthermore, TPA‐ICN/LVF@Lipo‐PyB significantly accelerates the healing of MRSA‐infected wounds by reducing inflammation, promoting angiogenesis, and enhancing collagen regeneration. These outstanding therapeutic results highlight the potential of this approach for the safe and effective clinical management of wound infections.
Open AccessA pH‐responsive charge‐reversal liposome with enhanced biofilm penetration for multimodal synergistic therapy of bacterial infections
Biofilm infections pose a significant clinical challenge largely due to the limited penetration of a variety of antibacterial agents, making traditional antibiotic therapies ineffective. In this study, we develop a pH‐responsive, charge‐reversal liposomal system (TPA‐ICN/LVF@Lipo‐PyB) loaded with the phototherapeutic agent TPA‐ICN and the antibiotic levofloxacin (LVF) for multimodal synergistic therapy of methicillin‐resistant Staphylococcus aureus (MRSA) biofilm infections. The surface‐grafted pyridine betaine group enables charge reversal of TPA‐ICN/LVF@Lipo‐PyB through rapid and efficient protonation to enhance its penetration capability in the acidic microenvironment of biofilms. Upon laser irradiation, the liposomal system exhibits both photodynamic and photothermal properties to inactivate bacteria within the biofilm. Simultaneously, the photothermal effect effectively disassembles the liposome due to the presence of thermosensitive phospholipids to trigger LVF release, ensuring the effective eradication of residual bacteria. Remarkably, the multimodal synergistic therapy demonstrates exceptional in vitro bacterial eradication, achieving a 99.99% reduction in MRSA biofilms. Furthermore, TPA‐ICN/LVF@Lipo‐PyB significantly accelerates the healing of MRSA‐infected wounds by reducing inflammation, promoting angiogenesis, and enhancing collagen regeneration. These outstanding therapeutic results highlight the potential of this approach for the safe and effective clinical management of wound infections.
- 29 April 2025
- Published by Springer Nature
- p. 1-12
Antibiotics Screening
- 29 December 2024
- Published by Wiley in Advanced Functional Materials
- Vol. 35 (17)
A pH‐Responsive, Surface Charge‐Switchable Nanosystem with Enhanced Biofilm Penetration for Synergistic Photodynamic and Antibiotic Therapy of Diabetic Wounds
Chronic wounds, particularly those associated with diabetes, pose a significant clinical challenge due to their tendency to develop biofilms that resist conventional antibiotic treatments. To address this issue, a novel therapeutic strategy utilizing pH‐responsive nanoparticles loaded with aggregation‐induced emission photosensitizers and natural saturated fatty acids (AIE/LA@HMONs−PyB) for effective biofilm penetration and disruption is proposed. Under physiological conditions, AIE/LA@HMONs−PyB are negatively charged. Upon accumulation at infected sites, however, the pyridine betaine group on the surface of AIE/LA@HMONs−PyB enables rapid protonation and charge reversal in the acidic biofilm microenvironment, thereby enhancing their ability to penetrate the biofilm. Upon light irradiation, these nanoparticles generate reactive oxygen species that effectively disrupt the biofilm structure. This process enables the synergistic action of ciprofloxacin at a lower concentration, achieving an exceptional in vitro antibacterial efficiency of 99.99% against methicillin‐resistant Staphylococcus aureus (S. aureus) biofilms. Furthermore, in an in vivo diabetic wound model, this synergistic therapy accelerates wound healing by reducing inflammation, promoting angiogenesis, and enhancing collagen regeneration. The enhanced penetration strategy significantly improves the therapeutic efficacy of this combined approach, offering great promise for advancing chronic wound healing and enhancing patient outcomes.
- 29 December 2024
- Published by Wiley in Advanced Functional Materials
- Vol. 35 (17)
A pH‐Responsive, Surface Charge‐Switchable Nanosystem with Enhanced Biofilm Penetration for Synergistic Photodynamic and Antibiotic Therapy of Diabetic Wounds
Chronic wounds, particularly those associated with diabetes, pose a significant clinical challenge due to their tendency to develop biofilms that resist conventional antibiotic treatments. To address this issue, a novel therapeutic strategy utilizing pH‐responsive nanoparticles loaded with aggregation‐induced emission photosensitizers and natural saturated fatty acids (AIE/LA@HMONs−PyB) for effective biofilm penetration and disruption is proposed. Under physiological conditions, AIE/LA@HMONs−PyB are negatively charged. Upon accumulation at infected sites, however, the pyridine betaine group on the surface of AIE/LA@HMONs−PyB enables rapid protonation and charge reversal in the acidic biofilm microenvironment, thereby enhancing their ability to penetrate the biofilm. Upon light irradiation, these nanoparticles generate reactive oxygen species that effectively disrupt the biofilm structure. This process enables the synergistic action of ciprofloxacin at a lower concentration, achieving an exceptional in vitro antibacterial efficiency of 99.99% against methicillin‐resistant Staphylococcus aureus (S. aureus) biofilms. Furthermore, in an in vivo diabetic wound model, this synergistic therapy accelerates wound healing by reducing inflammation, promoting angiogenesis, and enhancing collagen regeneration. The enhanced penetration strategy significantly improves the therapeutic efficacy of this combined approach, offering great promise for advancing chronic wound healing and enhancing patient outcomes.
- 13 September 2024
- Published by Elsevier in Chemical Engineering Journal
- Vol. 499
A straightforward strategy to modulate ROS generation of AIE photosensitizers for type-I PDT
- 13 September 2024
- Published by Elsevier in Chemical Engineering Journal
- Vol. 499
A straightforward strategy to modulate ROS generation of AIE photosensitizers for type-I PDT
- 28 June 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (27) , 11026-11035
Ultrasensitive Ratiometric Fluorescent Nanothermometer with Reverse Signal Changes for Intracellular Temperature Mapping
Sensing temperature at the subcellular level is pivotal for gaining essential thermal insights into diverse biological processes. However, achieving sensitive and accurate sensing of the intracellular temperature remains a challenge. Herein, we develop a ratiometric organic fluorescent nanothermometer with reverse signal changes for the ultrasensitive mapping of intracellular temperature. The nanothermometer is fabricated from a binary mixture of saturated fatty acids with a noneutectic composition, a red-emissive aggregation-caused quenching luminogen, and a green-emissive aggregation-induced emission luminogen using a modified nanoprecipitation method. Different from the eutectic mixture with a single phase-transition point, the noneutectic mixture possesses two solid-liquid phase transitions, which not only allows for reversible regulation of the aggregation states of the encapsulated luminogens but also effectively broadens the temperature sensing range (25-48 °C) across the physiological temperature range. Remarkably, the nanothermometer exhibits reverse and sensitive signal changes, demonstrating maximum relative thermal sensitivities of up to 63.66% °C-1 in aqueous systems and 44.01% °C-1 in the intracellular environment, respectively. Taking advantage of these outstanding thermometric performances, the nanothermometer is further employed to intracellularly monitor minute temperature variations upon chemical stimulation. This study provides a powerful tool for the exploration of dynamic cellular thermal activities, holding great promise in unveiling intricate physiological processes.
- 28 June 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (27) , 11026-11035
Ultrasensitive Ratiometric Fluorescent Nanothermometer with Reverse Signal Changes for Intracellular Temperature Mapping
Sensing temperature at the subcellular level is pivotal for gaining essential thermal insights into diverse biological processes. However, achieving sensitive and accurate sensing of the intracellular temperature remains a challenge. Herein, we develop a ratiometric organic fluorescent nanothermometer with reverse signal changes for the ultrasensitive mapping of intracellular temperature. The nanothermometer is fabricated from a binary mixture of saturated fatty acids with a noneutectic composition, a red-emissive aggregation-caused quenching luminogen, and a green-emissive aggregation-induced emission luminogen using a modified nanoprecipitation method. Different from the eutectic mixture with a single phase-transition point, the noneutectic mixture possesses two solid-liquid phase transitions, which not only allows for reversible regulation of the aggregation states of the encapsulated luminogens but also effectively broadens the temperature sensing range (25-48 °C) across the physiological temperature range. Remarkably, the nanothermometer exhibits reverse and sensitive signal changes, demonstrating maximum relative thermal sensitivities of up to 63.66% °C-1 in aqueous systems and 44.01% °C-1 in the intracellular environment, respectively. Taking advantage of these outstanding thermometric performances, the nanothermometer is further employed to intracellularly monitor minute temperature variations upon chemical stimulation. This study provides a powerful tool for the exploration of dynamic cellular thermal activities, holding great promise in unveiling intricate physiological processes.
- Open Access
A self‐regulated phototheranostic nanosystem with single wavelength‐triggered energy switching and oxygen supply for multimodal synergistic therapy of bacterial biofilm infections
The exploration of antibiotic‐independent phototherapy strategies for the treatment of bacterial biofilm infections has gained significant attention. However, efficient eradication of bacterial biofilms remains a challenge. Herein, a self‐regulated phototheranostic nanosystem with single wavelength‐triggered photothermal therapy (PTT)/photodynamic therapy (PDT) transformation and oxygen supply for multimodal synergistic therapy of bacterial biofilm infections is presented. This approach combines a eutectic mixture of natural phase‐change materials (PCMs) and an aggregation‐induced emission (AIE) phototheranostic agent TPA‐ICN to form colloidally stable nanopartcicles (i.e. AIE@PCM NPs). The reversible solid−liquid phase transition of PCMs facilitates the adaptive regulation of the aggregation states of TPA‐ICN, enabling a switch between the energy dissipation pathways for enhanced PDT in solid PCMs or enhanced PTT in liquid PCMs. Additionally, oxygen‐carrying thermoresponsive nanoparticles are also introduced to alleviate the hypoxic microenvironment of biofilms by releasing oxygen upon heating by AIE@PCM NPs with enhanced PTT. The nanosystem exhibits outstanding therapeutic efficacy against bacterial biofilms both in vitro and in vivo, with an antibacterial efficiency of 99.99%. This study utilizes a self‐regulated theranostic nanoplatform with adaptive PTT/PDT transformation via the phase transition of PCMs and heat‐triggered oxygen release, holding great promise in the safe and efficient treatment of bacterial biofilm infections.
Open AccessA self‐regulated phototheranostic nanosystem with single wavelength‐triggered energy switching and oxygen supply for multimodal synergistic therapy of bacterial biofilm infections
The exploration of antibiotic‐independent phototherapy strategies for the treatment of bacterial biofilm infections has gained significant attention. However, efficient eradication of bacterial biofilms remains a challenge. Herein, a self‐regulated phototheranostic nanosystem with single wavelength‐triggered photothermal therapy (PTT)/photodynamic therapy (PDT) transformation and oxygen supply for multimodal synergistic therapy of bacterial biofilm infections is presented. This approach combines a eutectic mixture of natural phase‐change materials (PCMs) and an aggregation‐induced emission (AIE) phototheranostic agent TPA‐ICN to form colloidally stable nanopartcicles (i.e. AIE@PCM NPs). The reversible solid−liquid phase transition of PCMs facilitates the adaptive regulation of the aggregation states of TPA‐ICN, enabling a switch between the energy dissipation pathways for enhanced PDT in solid PCMs or enhanced PTT in liquid PCMs. Additionally, oxygen‐carrying thermoresponsive nanoparticles are also introduced to alleviate the hypoxic microenvironment of biofilms by releasing oxygen upon heating by AIE@PCM NPs with enhanced PTT. The nanosystem exhibits outstanding therapeutic efficacy against bacterial biofilms both in vitro and in vivo, with an antibacterial efficiency of 99.99%. This study utilizes a self‐regulated theranostic nanoplatform with adaptive PTT/PDT transformation via the phase transition of PCMs and heat‐triggered oxygen release, holding great promise in the safe and efficient treatment of bacterial biofilm infections.